Cite
Clinical significance of immune cytokines in IFN therapy for chronic hepatitis C
MLA
Masaaki Miyaoka, et al. “Clinical Significance of Immune Cytokines in IFN Therapy for Chronic Hepatitis C.” Gastroenterology, vol. 120, Apr. 2001, p. A512. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....25280ea51b10ea40c1f2de02da1384eb&authtype=sso&custid=ns315887.
APA
Masaaki Miyaoka, Masahisa Takase, Taisei Shiratori, Michio Hidaka, Yoshinori Nishizato, & Kazuya Takeda. (2001). Clinical significance of immune cytokines in IFN therapy for chronic hepatitis C. Gastroenterology, 120, A512.
Chicago
Masaaki Miyaoka, Masahisa Takase, Taisei Shiratori, Michio Hidaka, Yoshinori Nishizato, and Kazuya Takeda. 2001. “Clinical Significance of Immune Cytokines in IFN Therapy for Chronic Hepatitis C.” Gastroenterology 120 (April): A512. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....25280ea51b10ea40c1f2de02da1384eb&authtype=sso&custid=ns315887.